Investor relations
Investors.
Building the national AI-readiness and clinical governance engine for Australian healthcare.
The opportunity
Australia's digital health market grows from A$8.9B (2025) to A$31.1B by 2034 (14.9% CAGR). Generative AI is projected to add ~A$13B per year to Australian healthcare by 2030. AI adoption remains early across ~7,000 GP clinics, ~24,905 specialist medical-services businesses, and tens of thousands of allied-health, dental and psychology practices. PwC warns of "an AI clean-up within 18 months as practices bolt on tools with no governance." Abe AI is the layer designed to prevent that clean-up.
The ask — current round
- Option A — A$2.0M focused seed. GP / primary-care beachhead. 18-month runway to ~A$1.5–2M ARR and Series A readiness.
- Option B — A$3.5–5M broad seed. Whole-of-health go-to-market. 18–24 months to multi-domain traction and Series A.
- Pre-build option. A leaner A$750k–A$1.5M pre-seed to prove the engine and first logos on the proven stack, then raise the larger seed on traction at a better valuation.
- Non-dilutive parallel. MRFF, National Reconstruction Fund, ARC Linkage, AI-adoption grants under the government's A$29.8M responsible-AI commitment.
Trajectory (illustrative — broad scenario)
| Year | Paying orgs | PHN / enterprise deals | Recognised revenue | ARR (year-exit) | Gross margin | Team |
|---|---|---|---|---|---|---|
| 1 | 120–160 | 1–2 | ~A$400–600k | ~A$550k | ~75% | ~12 |
| 2 | 500–700 | 4–8 | ~A$2.0–3.5M | ~A$3M | ~80% | ~20–28 |
| 3 | 1,400–2,200 | 10–18 | ~A$6–12M | ~A$9M | ~82% | ~35–50 |
All figures illustrative; verify with the founder before relying on them for any investment decision.
The moat
Founder credibility (achievement-led: direct Commission-facing clinical governance and telehealth accreditation experience, 100+ clinicians audited by hand, ships compliant health software). Australian-specific regulatory depth — TGA + AHPRA + OAIC + state — uniquely Australian, impossible to import. Safety-first brand. Governance data flywheel. Distribution via Black Health Intelligence sister ventures (TeleCheck, TeleScribe, Not Real Smart). Two proprietary knowledge bases — the Regulatory & Legislative Corpus and the Accreditation Standards Corpus — that no general LLM can replicate.
Team and build sequence
See /about for the founder and the journey end-to-end. Build sequence: MVP (Agents 0–3) → Phase 1 (+10 Tier 1 agents) → Phase 2 (+9 Tier 1 agents, Series A ready) → Phase 3 (Tier 2 clinical agents, TGA-gated).
Comparable transactions
- Telstra Health acquired MedicalDirector for AU$350M (2021) — GP PMS serving 23,000 practitioners, with no AI governance layer. Abe AI is that AI governance layer, built natively.
- Ambience Healthcare — ~US$243M raised — "AI operating system for healthcare workflows." The platform thesis funded.
Register interest
Investor Q&A
- What stage is Abe AI at?
- MVP (Months 0–3). Building the four MVP agents on the proven BHI stack. Validating with 50–100 early-signal logos via warm channels.
- Why is the company a venture of Black Health Intelligence Pty Ltd?
- BHI is the parent. Abe AI is the AI-readiness and governance venture. Other BHI ventures (TeleCheck, TeleScribe, Downscale, Not Real Smart) are warm channels and validate the founder's ability to ship compliant Australian health software at production scale.
- What is the moat against AMIDA Health AI, GetAIReady, and Big-Four consulting?
- Vendor-neutral (rates everyone's tools, including direct competitors'); priced for small practices; whole-of-health rather than specialist-only; clinician-built, with direct Commission-facing accreditation and clinical governance experience; future-ready (no competitor sells "stay ready for what's coming" — Abe AI does, through Horizon Scanning and Strategy & Future Planning agents).
- What is the regulatory risk?
- Abe AI is the governance layer above AI tools — it advises, the clinician decides. Tier 1 carries no SaMD obligations. Tier 2 (clinical decision support) is TGA-gated and does not activate until validation, ARTG and clinical-governance sign-off are confirmed.
- Why now?
- The regulation just crystallised (AHPRA 2024, ACSQHC August 2025, OAIC 2026, RACGP 6th Edition 2026, mandatory guardrails in consultation). Tools just got good (AI scribes cut documentation 50–70%). Adoption remains early and fragmented. AU AI investment hit ~A$1.0B in 2025; A$620M in Q1 2026 alone. The category leader has not emerged.
- Who is on the cap table today?
- BHI; founder. Pre-seed structure being defined. Cap-table details disclosed under NDA.
For NDA-gated material, founder direct conversations, or to register a fund's interest, use the form above. The founder responds within two business days.